Rodi Charles P 4
4 · Sorrento Therapeutics, Inc. · Filed Feb 9, 2010
Insider Transaction Report
Form 4
Rodi Charles P
VP, Research & Development
Transactions
- Award
Options to Purchase Common Stock
2010-02-05+120,000→ 120,000 totalExercise: $0.07Exp: 2020-02-05→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]This option vests over a four-year period commencing on November 2, 2009, with 25% of the share subject to the option vesting on each anniversary of the vesting commencement date.